Golden Ally Lifetech Group, Inc.
AQPW · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $1 | $1 | $2 |
| SG&A Expenses | $2 | $1 | $1 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $2 | $0 | $0 |
| Operating Expenses | $2 | $1 | $1 | $2 |
| Operating Income | -$2 | -$1 | -$1 | -$2 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | -$2 | -$1 | -$1 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$1 | -$1 | -$2 |
| % Margin | – | – | – | – |
| EPS | -0.033 | -0.015 | -0.017 | -0.02 |
| % Growth | -123.1% | 12% | 16.5% | – |
| EPS Diluted | -0.033 | -0.015 | -0.017 | -0.02 |
| Weighted Avg Shares Out | 74 | 74 | 85 | 79 |
| Weighted Avg Shares Out Dil | 74 | 74 | 85 | 79 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$1 | -$1 | -$2 |
| % Margin | – | – | – | – |